Investigation of Wearing Compliance of Spectacles for Myopia Control
NCT ID: NCT06590441
Last Updated: 2025-11-25
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
53 participants
OBSERVATIONAL
2024-09-30
2025-01-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management of Myopia in University Students Using Dual Focus Soft Contact Lenses
NCT05955638
Light Diffraction Glasses in Preventing and Controlling Myopia in Adolescents
NCT06927414
Different Microlenses Array for Controlling Myopia Progression in Children and Adolescents
NCT06926556
A Multi-center Study of the Effect of Orthokeratology on Myopia Progression
NCT04284111
An Evaluation of the Effectiveness of Dual Focus Soft Contact Lenses in Slowing Mypoia Progression
NCT01729208
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Myopia control spectacle wearers
Established (use of ≥3 months) juvenile myopia control spectacle wearers
Myopia control spectacles
Myopia control spectacles fitted with temperature sensors
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Myopia control spectacles
Myopia control spectacles fitted with temperature sensors
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Their parent or guardian understands the rights of the subject and are willing to sign a statement of informed consent.
3. They understand the study at a level appropriate for their age and are willing to sign a statement of assent.
4. They and their parents or guardians are willing and able to follow the protocol.
5. They currently use spectacle lenses for myopia control and have done so for at least three months.
6. They agree not to participate in other clinical research for the duration of this study.
Exclusion Criteria
2. They are amblyopic.
6 Years
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CooperVision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip Morgan
Role: PRINCIPAL_INVESTIGATOR
Eurolens Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eye2C Ltd
Sale, Cheshire, United Kingdom
Susan Hilton Ltd
Darwen, England, United Kingdom
Columbo Ltd
Oakwood, Leeds, United Kingdom
David Gould Opticians Limited
Haslingden, Rossendale, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EX-MKTG-160
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.